Hormone receptor positive

Hormone receptor positive refers to a type of cancer that is sensitive to hormones. This type of cancer has receptors for certain hormones, such as estrogen and progesterone, which can stimulate the cancer cells to grow. Hormone receptor positive cancers are often treated with hormone therapy.

Overview[edit | edit source]

Hormone receptor positive cancers are most commonly found in breast cancer and prostate cancer. In breast cancer, the presence of estrogen and progesterone receptors is a key factor in determining treatment options. Similarly, in prostate cancer, the presence of androgen receptors can influence treatment decisions.

Diagnosis[edit | edit source]

The diagnosis of hormone receptor positive cancer is made through a biopsy, where a sample of the tumor is examined under a microscope. The presence of hormone receptors can be determined through a process called immunohistochemistry.

Treatment[edit | edit source]

Treatment for hormone receptor positive cancers often involves hormone therapy. This can include drugs that block the production of hormones, such as aromatase inhibitors, or drugs that block the action of hormones, such as tamoxifen.

Prognosis[edit | edit source]

The prognosis for hormone receptor positive cancers is generally good, as these cancers often respond well to hormone therapy. However, the prognosis can vary depending on other factors, such as the stage of the cancer and the patient's overall health.

See also[edit | edit source]

Hormone receptor positive Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.